Minister for Business, Enterprise and Innovation, Heather Humphreys TD and IDA Ireland today welcomed the announcement that MSD is to develop a new biotechnology facility in Dublin, with the expected creation of up to 350 new jobs.
Known as MSD Biotech, Dublin, the facility will be constructed on an existing MSD-owned property, the site of its former facility in Swords, Co. Dublin.
MSD currently has four sites in Ireland – in Carlow, Cork, Dublin and Tipperary. Its extensive Irish operations, encompassing manufacturing, commercial, global financial services and marketing facilities, had a turnover of €4.7 billion in 2016.
The company has a strong legacy in Ireland that stretches back over the last 50 years. MSD provides healthcare solutions and innovative medicines in areas such as diabetes, heart disease, immuno-oncology, infectious diseases and vaccines.
Speaking today, Minister for Business, Enterprise and Innovation, Heather Humphreys said, "This investment by MSD is a great vote of confidence in Ireland. MSD has been a tremendous success story in this country with plants located in several centres, providing valuable employment. This new, cutting edge, Biotechnology facility will be a tremendous asset to our Pharma industry and will deepen the great partnership between the company and Ireland."
Ibec CEO, Danny McCoy added, "Ireland is home to the top 10 global biopharma companies and biopharma is now the largest exporting sector from Ireland. This has not happened by chance but is due to the business model Ireland has developed over decades that is capable of both attracting and retaining multinational investment."